Top Industry Leaders in the Asia Pacific Lancet Pen Needels Market
Latest Asia Pacific lancet and pen needles Companies Updates:
Terumo Corporation partners with HTL-Strefa S.A.: This November 2023 collaboration aims to expand Terumo's reach in the European lancet and pen needles market, leveraging HTL-Strefa's expertise and distribution network.
Owen Mumford Ltd. acquires Jiangsu Hengrui Medicine's diabetes care business: This December 2023 acquisition strengthens Owen Mumford's presence in the Chinese market, a key driver of growth in the APAC region.
BD (Becton, Dickinson and Company) launches SoloStar insulin delivery system in Japan: This October 2023 launch offers a user-friendly pen needle option for patients with diabetes in Japan.
Ypsomed develops smart pen needles with integrated sensors: These innovative needles have the potential to improve insulin dosing accuracy and diabetes management through data collection and insights.
List of Asia Pacific lancet and pen needles Key companies in the market:
- BD. (U.S.)
- Novo Nordisk A/S (Europe)
- Ypsomed (Europe)
- B. Braun Melsungen AG (Europe)
- HTL-STREFA (Europe)
- Terumo Corporation (Asia Pacific)
- Artsana S.p.A. (Europe)
- Owen Mumford Ltd. (Europe)